Galmed posts initial results from late-stage Aramchol NASH and liver fibrosis trial
01 Novembro 2021 - 11:19AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Galmed Pharmaceuticals (NASDAQ:GLMD)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Galmed Pharmaceuticals (NASDAQ:GLMD)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024